Antidepressants are medications that normalize pathologically changed depressive mood and contribute to the reduction of somatovegetative, cognitive, and motor manifestations caused by depression.
With antidepressants being the third most common psychiatric drug prescribed, the World Health Organization predicts that unipolar depression“will be the second most prevalent cause of illness-induced disability by the year 2020.”.
And in the FDA formulation:“Antidepressant medicines may increase suicidal thoughts or actions in some children, teenagers, and young adults within the first few months of treatment.”.
The current standard treatments of psychological therapy and antidepressant medications are not effective for everyone, and psychotropic drugs may be associated with significant adverse effects.
While antidepressants do increase the levels of the neurotransmitter serotonin in the brain, this doesn't mean that depression is caused by a serotonin shortage.
Some antidepressants have lower risk for the baby during pregnancy, but the FDA advises for the risk of birth defects with the use of Paxil[68] and the MAOI should be avoided.
Antidepressants have the most sales worldwide and, according to statistics from the World Health Organization(WHO), the percentage of people is between 10% to 15%.
Antidepressants are typically prescribed at a low dose for insomnia, but the supporting evidence of efficacy(despite the wide use) is low quality and there is the risk of adverse effects such as confusion, dry mouth, and blurred vision.
Sept. 4, 2019(HealthDay News)-- Antidepressants typically take four to eight weeks to ease the debilitating symptoms of depression, but an early clinical trial found a new type of drug brought relief in just two weeks.
Before this FDA Health Advisory was issued, clinical experience and the results of small clinical trials suggested that antidepressants can be safely administered to adult cancer patients, although there are no controlled clinical trials to support this position.
Background Reports claiming that antidepressants are effective only in patients with severe depression have affected treatment guidelines but these reports usually use a disputed measure of improvement, a decrease in the sum-score of the 17-item Hamilton Depression Rating Scale(HDRS-17), and are based on group-level rather than patient-level data.
またはSSRI,プロザックなど,または他の抗うつ薬は、この製品を取ることが必要。
or any other anti-depressant medication should not take this product.
English
中文
عربى
Български
বাংলা
Český
Dansk
Deutsch
Ελληνικά
Español
Suomi
Français
עִברִית
हिंदी
Hrvatski
Magyar
Bahasa indonesia
Italiano
Қазақ
한국어
മലയാളം
मराठी
Bahasa malay
Nederlands
Norsk
Polski
Português
Română
Русский
Slovenský
Slovenski
Српски
Svenska
தமிழ்
తెలుగు
ไทย
Tagalog
Turkce
Українська
اردو
Tiếng việt